Long-Term Follow-up Study
Public ClinicalTrials.gov record NCT05332054. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Observational Long-Term Follow-up Study of Patients Who Received Prior Caribou Cell Therapy
Study identification
- NCT ID
- NCT05332054
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Caribou Biosciences, Inc.
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Not listed
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 15, 2022
- Primary completion
- Nov 30, 2041
- Completion
- Nov 30, 2041
- Last update posted
- Mar 11, 2026
2022 – 2041
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35233 | — |
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| Honor Health Research Institute | Scottsdale | Arizona | 85258 | — |
| University of California Irvine | Irvine | California | 92868 | — |
| University of California San Diego | La Jolla | California | 92093 | — |
| University of Colorado | Denver | Colorado | 80045 | — |
| Colorado Blood Cancer Institute | Denver | Colorado | 80218 | — |
| University of Miami | Miami | Florida | 33136 | — |
| AdventHealth Medical Group Blood & Marrow Transplant at Orlando | Orlando | Florida | 32804 | — |
| Blood & Marrow Transplant Group of Georgia | Atlanta | Georgia | 30342 | — |
| Augusta University/Georgia Cancer Center | Augusta | Georgia | 30912 | — |
| University of Iowa Hospitals & Clinics | Iowa City | Iowa | 52242 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40207 | — |
| Regional Cancer Care Associates - Hackensack | Hackensack | New Jersey | 07601 | — |
| Atlantic Health System Cancer Care | Morristown | New Jersey | 07960 | — |
| Weill Cornell Medicine | New York | New York | 10021 | — |
| Icahn School of Medicine at Mt. Sinai | New York | New York | 10029 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Levine Cancer Center | Charlotte | North Carolina | 28204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05332054, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2026 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05332054 live on ClinicalTrials.gov.